Skip to content

The clinical observation of two different insert methods of the LMA Protector™ mask

The clinical observation of two different insert methods of the LMA Protector™ mask

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071810
Enrollment
Unknown
Registered
2023-05-25
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway management for patients undergoing painless fiberoptic bronchoscope

Interventions

Group A:Insertion LMA protector with regular method
Group B:Insertion LMA protector with assistant method

Sponsors

The First Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing painless fiberoptic bronchoscope 2. 18-75 years old, voluntarily cooperate to complete the entire experimental process ; 3. American Society of Anesthesiologists classification (ASA), I-III. 4. After anesthesia assessment, the patient/family member has informed consent and signed a consent form; 5. The patient's general clinical information is complete.

Exclusion criteria

Exclusion criteria: 1.Predictable difficult airway; 2.Previous oral trauma, burns, etc., mouth opening 35 kg/m2; 5.History of severe gastroesophageal reflux and symptoms of seizures recently 6.High risk of reflux aspiration; 7.A combination of psychiatric diseaseor history of allergy to conventional anesthetic drugs.

Design outcomes

Primary

MeasureTime frame
Incidence rate of blood stains on LMA Protector body;Incidence rate of postoperation sore throat;

Secondary

MeasureTime frame
insertion time;insertion times;ease of insertion ;Bronchoscopy visual field classification;OLP;Hemodynamic indicators;Respiratory mechanics indicators;Tidal volume, VT;

Countries

China

Contacts

Public ContactLiu Shujie

The first affiliated hospital of Harbin Medical University

shujieliu312@163.com+86 451 8555 3159

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026